Sertindole — CAS 17034-35-4

Sertindole is an atypical antipsychotic agent used in the treatment of schizophrenia. It acts primarily through D2, 5-HT2A, 5-HT2C, and α1-adrenoceptor antagonism, with low affinity for muscarinic and histaminergic receptors — resulting in minimal extrapyramidal side effects and sedation. Mediocon Inc supplies GMP-certified Sertindole API to pharmacopoeial grade standards for neuropsychiatric formulation manufacturers.

• Schizophrenia treatment
• D2 / 5-HT2A receptor antagonism
• Low EPS-profile antipsychotic
• Neuropsychiatric formulations

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support